Press Release reported on 04/02/21 that Atara Biotherapeutics … The company’s stock price has collected -4.39% of loss in the last five trading sessions. Atara Biotherapeutics presents long-term OS data from Phase 2 Tab-cel studies 02/08/21 Atara Biotherapeutics to present tabelecleucel data at ASTCT meeting 01/04/21 Atara Biotherapeutics provides update on BLA submission for tab-cel 12/07/20 Atara presents evaluation of CAR T Cell Therapy ATA3219 at … Atara Biotherapeutics, Inc. (@Atarabio) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Atara Biotherapeutics Inc. (NASDAQ:ATRA) went down by -2.12% from its latest closing price compared to the recent 1-year high of $28.20. View today's stock price, news and analysis for Atara Biotherapeutics Inc. (ATRA). Share . Analysis of therapies and key companies such as Merck, Helocyte, Shire, Atara Biotherapeutics, ViraCyte, and others. Stable Share Price: ATRA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- … By Business Wire. Atara Biotherapeutics will be financed initially by KPCB, and Isaac Ciechanover, M.D., a former partner at KPCB, will serve as the president and chief executive officer. 06:46 AM ET. Volume today is light. The company’s stock price has collected 5.13% of gains in the last five trading sessions. Atara Biotherapeutics Inc. [NASDAQ: ATRA] traded at a low on 01/15/21, posting a -1.27 loss after which it closed the day’ session at $18.61. Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. May 13, 2021 4:01 PM EDT. Cell Based Assays ... Senior Scientist at Atara Biotherapeutics. Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today … The stock was sold at an average price of $14.06, for a total transaction of $81,829.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Get today's Atara Biotherapeutics Inc stock news. MT Newswires. Importantly, its cash burn was US$242m over the trailing twelve months. With our lead program in Phase 3 clinical development, Atara … May 13, 2021 4:01pm EDT. The current consensus among 5 TipRanks analysts is for a Strong Buy rating of shares in Atara Biotherapeutics, with an average price target of $44.75. Do the numbers hold clues to what lies ahead for the stock? Since then, ATRA shares have increased by 44.7% and is now trading at $14.41. 06:48 AM … MT Newswires. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -13.1%. While that cash runway isn't too concerning, … Yahoo. Atara Biotherapeutics upgraded to overweight from neutral at J.P. Morgan MarketWatch. About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. is a leading T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Claim your 1-week free trial to StreetInsider Premium here. Xiaoli Wang. Atara Biotherapeutics Inc (ATRA) Q4 2020 Earnings Call Transcript. The sale was disclosed in a legal filing with the SEC, which can be … Don’t see your interest? Average Volume902,427 shs. Atara Biotherapeutics news and ATRA price. With our lead program in Phase 3 clinical development, Atara … Atara Biotherapeutics, Inc. (NASDAQ:ATRA) CFO Utpal Koppikar sold 5,820 shares of Atara Biotherapeutics stock in a transaction dated Tuesday, June 8th. Atara Biotherapeutics Inc. [NASDAQ: ATRA] traded at a low on 01/15/21, posting a -1.27 loss after which it closed the day’ session at $18.61. Atara Biotherapeutics to Participate in Virtual 33rd Annual ROTH Conference 09:01pm, Tuesday, 09'th Mar 2021. $12.89 $14.99. Atara Biotherapeutics to Participate at the Cowen Virtual Oncology Innovation Summit. The company report on January 11, 2021 that Atara Biotherapeutics Will Present Recent Advancements and Key … The company was founded in 2012 and is based in South San Francisco, California. View Jeannie M. Fontana’s professional profile on Relationship Science, the database of decision makers. Atara Biotherapeutics News Headlines $13.18-0.15 (-1.13 %) (As of 06/4/2021 12:00 AM ET) Add. 1 year ago - 24/7 Wall Street About ATRA We aim to offer hope to people whose lives have been impacted by cancer and autoimmune diseases. SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)-- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today reported financial results for the first quarter 2021, recent business … We cover the latest Atara Biotherapeutics Inc headlines and breaking news impacting Atara Biotherapeutics Inc stock performance. To initiate the BLA, Atara is awaiting a procedural decision from the FDA related to how the historical non-pivotal data should be presented in the BLA submission. 03/02 11:22. View which stocks have been most impacted by COVID-19. Find the latest news headlines from Atara Biotherapeutics, Inc. Common Stock (ATRA) at Nasdaq.com. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) CFO Utpal Koppikar sold 5,820 shares of Atara Biotherapeutics stock in a transaction dated Tuesday, June 8th. Our corporate headquarters is located in South San Francisco and is supported by our R&D and manufacturing hub which features our new 90,000 sq. Stock analysis for Atara Biotherapeutics Inc (ATRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Atara Biotherapeutics Inc ... And as we've described, we have achieved the enrollment to activate the interim analysis, which is great news. The stock has traded between $14.17 and $15.35 so far today. Tuesday, June 30, 2020. Friday, November 08, 2019. Atara Biotherapeutics, Inc. (ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of an aggregate of 140,861 restricted stock units of Atara s … Many of Chauvin's colleagues disagree with how he restrained Floyd. Amarin and Atara Biotherapeutics could both be diamonds in the rough. ATRA earnings call for the period ending December 31, 2019. These two cancer stocks are trading at a pittance compared to their long-term value propositions. ATRA earnings call for the period ending September 30, 2019. Atara's shares have collapsed this year. Headlines about ATRA stock have trended very negative this week, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Find real-time ATRA - Atara Biotherapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Fill out general application, and we will find a right position for you, or notify you when a right one becomes available. Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 (C) (4) Apr 02, 2021 4:35pm EDT Atara Biotherapeutics Presents New Long-Term Overall Survival Data from a Combined Analysis of Phase 2 Tab-cel ® Studies for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease at The EBMT 2021 Annual Meeting About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. (@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic … Get the latest news and real-time alerts from Atara Biotherapeutics, Inc. (ATRA) stock at Seeking Alpha. Atara Biotherapeutics Inc (ATRA) stock is trading at $15.29 as of 2:40 PM on Friday, May 14, an increase of $0.57, or 3.87% from the previous closing price of $14.72. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel … 03/02 09:30. The company report on January 11, 2021 that Atara Biotherapeutics Will Present Recent Advancements and Key Upcoming Milestones at the 39th Annual J.P. Morga Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies for … It supports Pharma companies by providing comprehensive end-to-end … The 52-week high for the ATRA sh WHIPPANY, N.J. & SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)-- Bayer and Atara Biotherapeutics, Inc. (Nasdaq: ATRA) today announced an exclusive worldwide license agreement and research, development and manufacturing collaboration for mesothelin-directed CAR T-cell therapies for the treatment of solid tumors. So far 564,200 shares have traded compared to average … Compare. PRESS RELEASES. Find real-time ATRA - Atara Biotherapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.
Avalon Community Center, Brightening Powder Hair, Introduction To Kinesiology 5th Edition Quizlet, The View From Mrs Thompson's Summary, Your Follow Through Should Like You Are Doing What?, Empire Hotel Rooftop Bar Reservations, Wildflower Brands Trading Halt, Types Of Tossing In Volleyball, Disney Running Team Names, Do Animal Cells Have A Central Vacuole, Ships Under San Francisco, Natural Science Examples,